Alpharix-Tetra

DRUG2 trials

Sponsors

GlaxoSmithKline Biologicals, GlaxoSmithKline Biologicals, CHU De Liege

Conditions

Healthy volunteers (prevention of influenza infection)Hematological cancer

Phase 1

A Phase 1/2, randomized, dose-finding/dose-confirmation study to evaluate the reactogenicity, safety and immunogenicity of mRNA-based multivalent seasonal influenza vaccine candidates administered in healthy younger and older adults

CompletedCTIS2022-502308-66-00

GlaxoSmithKline Biologicals, GlaxoSmithKline BiologicalsHealthy volunteers (prevention of influenza infection)

Start: 2023-04-27End: 2024-07-02Target: 438Updated: 2024-05-27

Phase 3

A Single-Blind randomized trial of High-Dose versus Standard-Dose Inactivated Influenza Vaccine in Adult Patients Treated for an Hematological Cancer (Flu-Hemato-Rando study)

RecruitingCTIS2023-505357-40-00

CHU De LiegeHematological cancer

Start: 2023-09-18Target: 180Updated: 2023-08-23